Literature DB >> 6622685

Local thrombolytic therapy for subclavian and axillary vein thrombosis. Treatment of the thoracic inlet syndrome.

G J Becker, R W Holden, F E Rabe, W R Castaneda-Zuniga, N Sears, R S Dilley, J L Glover.   

Abstract

Four patients with primary subclavian-axillary vein thrombosis are described. Each patient received local thrombolytic therapy, resulting in reestablishment of antegrade flow via the axillary and subclavian veins. An intrinsic venous abnormality (perimural fibrosis and/or intimal dissection) identified at the first rib-clavicle junction (subclavian-axillary vein junction) was thought to be responsible for the thrombosis. One of the four patients subsequently underwent a surgical venous bypass of the abnormal segment, and a second underwent percutaneous transluminal angioplasty.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6622685     DOI: 10.1148/radiology.149.2.6622685

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  4 in total

1.  Low-dose streptokinase thrombolysis of axillary-subclavian vein thrombosis.

Authors:  H Huey; D C Morris; D M Nichols; D G Connell; P D Fry
Journal:  Cardiovasc Intervent Radiol       Date:  1987       Impact factor: 2.740

2.  Selective low-dose streptokinase infusion in the treatment of acute transplant renal vein thrombosis.

Authors:  J M Robinson; C H Cockrell; J Tisnado; M C Beachley; M P Posner; T F Tracy
Journal:  Cardiovasc Intervent Radiol       Date:  1986       Impact factor: 2.740

3.  Streptokinase: an antidotal case.

Authors:  S I Long
Journal:  J Natl Med Assoc       Date:  1986-05       Impact factor: 1.798

4.  Effort thrombosis: role of interventional therapy.

Authors:  C J Grassi; M A Bettmann
Journal:  Cardiovasc Intervent Radiol       Date:  1990 Oct-Nov       Impact factor: 2.740

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.